These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22108766)

  • 1. Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases.
    Shin NY; Kim MJ; Lim JS; Park MS; Chung YE; Choi JY; Kim KW; Park YN
    Eur Radiol; 2012 Apr; 22(4):864-71. PubMed ID: 22108766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance assessment of sinusoidal obstruction syndrome after neoadjuvant chemotherapy for colorectal liver metastases is not reproducible.
    Staal FC; Beets-Tan RG; Heeres BC; Houwers J; de Boer M; van Dorth D; Lambregts DM; Maas M
    Acta Radiol; 2021 Sep; 62(9):1133-1141. PubMed ID: 32972213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between Gd-EOB-DTPA-enhanced MR imaging findings and OATP1B3 expression in chemotherapy-associated sinusoidal obstruction syndrome.
    Yoneda N; Matsui O; Ikeno H; Inoue D; Yoshida K; Kitao A; Kozaka K; Kobayashi S; Gabata T; Ikeda H; Nakamura K; Ohta T
    Abdom Imaging; 2015 Oct; 40(8):3099-103. PubMed ID: 26187715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Gadoxetic acid-enhanced 3.0T MRI in addition to 64-detector-row contrast-enhanced CT provide better diagnostic performance and change the therapeutic strategy for the preoperative evaluation of colorectal liver metastases?
    Sofue K; Tsurusaki M; Murakami T; Onoe S; Tokue H; Shibamoto K; Arai Y; Sugimura K
    Eur Radiol; 2014 Oct; 24(10):2532-9. PubMed ID: 24865698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gd-EOB-DTPA-enhanced MR findings in chemotherapy-induced sinusoidal obstruction syndrome in colorectal liver metastases.
    Ding Y; Rao SX; Wang WT; Chen CZ; Li RC; Zeng M
    J Int Med Res; 2020 Jun; 48(6):300060520926031. PubMed ID: 32500783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of gadoxetic acid-enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection.
    Granata V; Fusco R; de Lutio di Castelguidone E; Avallone A; Palaia R; Delrio P; Tatangelo F; Botti G; Grassi R; Izzo F; Petrillo A
    BMC Gastroenterol; 2019 Jul; 19(1):129. PubMed ID: 31340755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sinusoidal obstructive syndrome diagnosed with superparamagnetic iron oxide-enhanced magnetic resonance imaging in patients with chemotherapy-treated colorectal liver metastases.
    Ward J; Guthrie JA; Sheridan MB; Boyes S; Smith JT; Wilson D; Wyatt JI; Treanor D; Robinson PJ
    J Clin Oncol; 2008 Sep; 26(26):4304-10. PubMed ID: 18779617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastases.
    Chung WS; Kim MJ; Chung YE; Kim YE; Park MS; Choi JY; Kim KW
    J Magn Reson Imaging; 2011 Aug; 34(2):345-53. PubMed ID: 21702068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of contrast-enhanced CT-scan in sinusoidal obstruction syndrome induced by chemotherapy of colorectal liver metastases: Radio-pathological correlation.
    Cayet S; Pasco J; Dujardin F; Besson M; Orain I; De Muret A; Miquelestorena-Standley E; Thiery J; Genet T; Le Bayon AG
    Eur J Radiol; 2017 Sep; 94():180-190. PubMed ID: 28712693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disappearing or residual tiny (≤5 mm) colorectal liver metastases after chemotherapy on gadoxetic acid-enhanced liver MRI and diffusion-weighted imaging: Is local treatment required?
    Kim SS; Song KD; Kim YK; Kim HC; Huh JW; Park YS; Park JO; Kim ST
    Eur Radiol; 2017 Jul; 27(7):3088-3096. PubMed ID: 27815722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases.
    Koh DM; Collins DJ; Wallace T; Chau I; Riddell AM
    Br J Radiol; 2012 Jul; 85(1015):980-9. PubMed ID: 22167501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The target sign in colorectal liver metastases: an atypical Gd-EOB-DTPA "uptake" on the hepatobiliary phase of MR imaging.
    Granata V; Catalano O; Fusco R; Tatangelo F; Rega D; Nasti G; Avallone A; Piccirillo M; Izzo F; Petrillo A
    Abdom Imaging; 2015 Oct; 40(7):2364-71. PubMed ID: 26105523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome.
    Soubrane O; Brouquet A; Zalinski S; Terris B; Brézault C; Mallet V; Goldwasser F; Scatton O
    Ann Surg; 2010 Mar; 251(3):454-60. PubMed ID: 20160638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.
    Rimola J; Forner A; Sapena V; Llarch N; Darnell A; Díaz A; García-Criado A; Bianchi L; Vilana R; Díaz-González Á; Ayuso C; Bruix J; Reig M
    Eur Radiol; 2020 Jan; 30(1):186-194. PubMed ID: 31372783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI.
    Muhi A; Ichikawa T; Motosugi U; Sou H; Nakajima H; Sano K; Sano M; Kato S; Kitamura T; Fatima Z; Fukushima K; Iino H; Mori Y; Fujii H; Araki T
    J Magn Reson Imaging; 2011 Aug; 34(2):326-35. PubMed ID: 21780227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of gadoxetic acid-enhanced dynamic MR imaging and contrast-enhanced computed tomography for preoperative evaluation of colorectal liver metastases.
    Asato N; Tsurusaki M; Sofue K; Hieda Y; Katsube T; Kitajima K; Murakami T
    Jpn J Radiol; 2017 Apr; 35(4):197-205. PubMed ID: 28251499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of contrast-enhanced ultrasonograpy with Gd-EOB-DTPA-enhanced MRI in the diagnosis of liver metastasis from colorectal cancer.
    Shiozawa K; Watanabe M; Ikehara T; Matsukiyo Y; Kogame M; Kikuchi Y; Otsuka Y; Kaneko H; Igarashi Y; Sumino Y
    J Clin Ultrasound; 2017 Mar; 45(3):138-144. PubMed ID: 27861987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
    Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional value of gadoxetic acid-DTPA-enhanced hepatobiliary phase MR imaging in the diagnosis of early-stage hepatocellular carcinoma: comparison with dynamic triple-phase multidetector CT imaging.
    Haradome H; Grazioli L; Tinti R; Morone M; Motosugi U; Sano K; Ichikawa T; Kwee TC; Colagrande S
    J Magn Reson Imaging; 2011 Jul; 34(1):69-78. PubMed ID: 21598343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.
    Donati OF; Hany TF; Reiner CS; von Schulthess GK; Marincek B; Seifert B; Weishaupt D
    J Nucl Med; 2010 May; 51(5):692-9. PubMed ID: 20395324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.